Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05569356
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-10-13
First Post:
2022-09-14
Brief Title:
Diagnostic Contribution Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy ACORE
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Biomarkers of Inflammation and Autoimmunity Diagnostic Contribution Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACORE
Brief Summary:
This study aims to identify novel inflammatory biomarkers in AC whether in circulating blood in situ or as imaging biomarkers to better understand the pathophysiology of the disease and then to determine contribution to the clinical management of patients
Detailed Description:
The treatment of AC remains based on palliative measures aimed at treating the consequences of the disease antiarrhythmic treatments defibrillator treatments for heart failure The identification of new biomarkers in particular circulating ones would make it possible to open pathophysiology avenues which in the long term could lead to therapies targeted to autoimmunity or inflammation
Many scientific and medical questions remain unanswered and require precise databases on the diagnostic and prognostic evaluation of this pathology
The objective of this study is to identify novel inflammatory biomarkers in patients with AC by studying the autoimmunity inflammatory and immunological profiles through blood samples and myocardial biopsies
Many scientific and medical questions remain unanswered and require precise databases on the diagnostic and prognostic evaluation of this pathology
The objective of this study is to identify novel inflammatory biomarkers in patients with AC by studying the autoimmunity inflammatory and immunological profiles through blood samples and myocardial biopsies
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2022-A00283-40 | OTHER | ANSM | None |